Recent advances of anti-cancer therapies including the use of cell-penetrating peptides

被引:35
作者
Klimpel, Annika [1 ]
Luetzenburg, Tamara [1 ]
Neundorf, Ines [1 ]
机构
[1] Univ Cologne, Dept Chem, Biochem, Zulpicher Str 47a, D-50674 Cologne, Germany
关键词
SIRNA DELIVERY; IN-VITRO; CANCER; NANOPARTICLES; CONJUGATE; MEMBRANE; EFFICACY; DOXORUBICIN; LIPOSOMES; MICELLES;
D O I
10.1016/j.coph.2019.01.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cancer is one of the major growing public health problems making the development of new anti-cancer treatment strategies still compulsory. Conventionally used chemotherapies are quite often associated with severe side effects. One reason is limited cell-permeability of the used drugs resulting in only poor overall bioavailability. During the last thirty years, cell-penetrating peptides (CPPs) have extensively been studied as efficient vehicles for several classes of cargos, and the development of novel therapeutic applications including CPPs has gained a major role in current cancer research. This review summarizes recent trends in CPP-mediated cargo delivery with a future impact on anti-cancer therapy.
引用
收藏
页码:8 / 13
页数:6
相关论文
共 54 条
[1]   PEGylation rate influences peptide-based nanoparticles mediated siRNA delivery in vitro and in vivo [J].
Aldrian, Gudrun ;
Vaissiere, Anais ;
Konate, Karidia ;
Seisel, Quentin ;
Vives, Eric ;
Fernandez, Frederic ;
Viguier, Veronique ;
Genevois, Coralie ;
Couillaud, Franck ;
Demene, Helene ;
Aggad, Dina ;
Covinhes, Aurelie ;
Barrere-Lemaire, Stephanie ;
Deshayes, Sebastien ;
Boisguerin, Prisca .
JOURNAL OF CONTROLLED RELEASE, 2017, 256 :79-91
[2]   Peptide-based targeted therapeutics: Focus on cancer treatment [J].
Araste, Fatemeh ;
Abnous, Khalil ;
Hashemi, Maryam ;
Taghdisi, Seyed Mohammad ;
Ramezani, Mohammad ;
Alibolandi, Mona .
JOURNAL OF CONTROLLED RELEASE, 2018, 292 :141-162
[3]   Cell-penetrating peptides: 20 years later, where do we stand? [J].
Bechara, Cherine ;
Sagan, Sandrine .
FEBS LETTERS, 2013, 587 (12) :1693-1702
[4]   Cell Penetrating Peptides as Molecular Carriers for Anti-Cancer Agents [J].
Borrelli, Antonella ;
Tornesello, Anna Lucia ;
Tornesello, Maria Lina ;
Buonaguro, Franco M. .
MOLECULES, 2018, 23 (02)
[5]   Structure optimisation to improve the delivery efficiency and cell selectivity of a tumour-targeting cell-penetrating peptide [J].
Cao, Xue-Wei ;
Yang, Xu-Zhong ;
Du, Xuan ;
Fu, Long-Yun ;
Zhang, Tao-Zhu ;
Shan, Han-Wen ;
Zhao, Jian ;
Wang, Fu-Jun .
JOURNAL OF DRUG TARGETING, 2018, 26 (09) :777-792
[6]   Dual-targeted peptide-conjugated multifunctional fluorescent probe with AIEgen for efficient nucleus-specific imaging and long-term tracing of cancer cells [J].
Cheng, Yong ;
Sun, Chunli ;
Ou, Xiaowen ;
Liu, Bifeng ;
Lou, Xiaoding ;
Xia, Fan .
CHEMICAL SCIENCE, 2017, 8 (06) :4571-4578
[7]  
DEROSSI D, 1994, J BIOL CHEM, V269, P10444
[8]   Cell-penetrating peptides:: Mechanisms and applications [J].
El-Andaloussi, S ;
Holm, T ;
Langel, Ü .
CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (28) :3597-3611
[9]   VE-cadherin-derived cell-penetrating peptide, pVEC, with carrier functions [J].
Elmquist, A ;
Lindgren, M ;
Bartfai, T ;
Langel, U .
EXPERIMENTAL CELL RESEARCH, 2001, 269 (02) :237-244
[10]   PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation [J].
Ezzat, Kariem ;
EL Andaloussi, Samir ;
Zaghloul, Eman M. ;
Lehto, Taavi ;
Lindberg, Staffan ;
Moreno, Pedro M. D. ;
Viola, Joana R. ;
Magdy, Tarek ;
Abdo, Rania ;
Guterstam, Peter ;
Sillard, Rannar ;
Hammond, Suzan M. ;
Wood, Matthew J. A. ;
Arzumanov, Andrey A. ;
Gait, Michael J. ;
Smith, C. I. Edvard ;
Hallbrink, Mattias ;
Langel, Ulo .
NUCLEIC ACIDS RESEARCH, 2011, 39 (12) :5284-5298